Logo image of PDEX

PRO-DEX INC (PDEX) Stock Fundamental Analysis

USA - NASDAQ:PDEX - US74265M2052 - Common Stock

36.89 USD
+0.99 (+2.76%)
Last: 11/4/2025, 12:50:52 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PDEX. PDEX was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While PDEX has a great profitability rating, there are some minor concerns on its financial health. PDEX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PDEX was profitable.
In the past year PDEX has reported a negative cash flow from operations.
PDEX had positive earnings in each of the past 5 years.
In multiple years PDEX reported negative operating cash flow during the last 5 years.
PDEX Yearly Net Income VS EBIT VS OCF VS FCFPDEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

1.2 Ratios

With an excellent Return On Assets value of 14.68%, PDEX belongs to the best of the industry, outperforming 95.77% of the companies in the same industry.
With an excellent Return On Equity value of 24.52%, PDEX belongs to the best of the industry, outperforming 95.77% of the companies in the same industry.
The Return On Invested Capital of PDEX (17.81%) is better than 96.30% of its industry peers.
PDEX had an Average Return On Invested Capital over the past 3 years of 14.16%. This is significantly above the industry average of 9.06%.
The 3 year average ROIC (14.16%) for PDEX is below the current ROIC(17.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.68%
ROE 24.52%
ROIC 17.81%
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
PDEX Yearly ROA, ROE, ROICPDEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

PDEX's Profit Margin of 13.49% is amongst the best of the industry. PDEX outperforms 89.42% of its industry peers.
In the last couple of years the Profit Margin of PDEX has declined.
The Operating Margin of PDEX (16.05%) is better than 85.19% of its industry peers.
In the last couple of years the Operating Margin of PDEX has declined.
PDEX has a Gross Margin of 29.30%. This is in the lower half of the industry: PDEX underperforms 76.19% of its industry peers.
In the last couple of years the Gross Margin of PDEX has declined.
Industry RankSector Rank
OM 16.05%
PM (TTM) 13.49%
GM 29.3%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
PDEX Yearly Profit, Operating, Gross MarginsPDEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PDEX is creating value.
PDEX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PDEX has been reduced compared to 5 years ago.
PDEX has a worse debt/assets ratio than last year.
PDEX Yearly Shares OutstandingPDEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
PDEX Yearly Total Debt VS Total AssetsPDEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

An Altman-Z score of 6.00 indicates that PDEX is not in any danger for bankruptcy at the moment.
PDEX has a Altman-Z score of 6.00. This is amongst the best in the industry. PDEX outperforms 83.07% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that PDEX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.25, PDEX is in line with its industry, outperforming 54.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 6
ROIC/WACC2.14
WACC8.32%
PDEX Yearly LT Debt VS Equity VS FCFPDEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

PDEX has a Current Ratio of 3.23. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
PDEX has a better Current ratio (3.23) than 62.43% of its industry peers.
A Quick Ratio of 1.71 indicates that PDEX should not have too much problems paying its short term obligations.
PDEX's Quick ratio of 1.71 is in line compared to the rest of the industry. PDEX outperforms 46.03% of its industry peers.
Industry RankSector Rank
Current Ratio 3.23
Quick Ratio 1.71
PDEX Yearly Current Assets VS Current LiabilitesPDEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

4

3. Growth

3.1 Past

PDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.14%, which is quite impressive.
The Earnings Per Share has been growing by 10.96% on average over the past years. This is quite good.
Looking at the last year, PDEX shows a very strong growth in Revenue. The Revenue has grown by 23.68%.
PDEX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.84% yearly.
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
Revenue 1Y (TTM)23.68%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PDEX Yearly Revenue VS EstimatesPDEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
PDEX Yearly EPS VS EstimatesPDEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.56, the valuation of PDEX can be described as reasonable.
PDEX's Price/Earnings ratio is rather cheap when compared to the industry. PDEX is cheaper than 89.95% of the companies in the same industry.
PDEX is valuated cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 15.20, which indicates a correct valuation of PDEX.
Based on the Price/Forward Earnings ratio, PDEX is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
PDEX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.53, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.56
Fwd PE 15.2
PDEX Price Earnings VS Forward Price EarningsPDEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PDEX is valued cheaper than 90.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10
PDEX Per share dataPDEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PDEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.06
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PDEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PRO-DEX INC

NASDAQ:PDEX (11/4/2025, 12:50:52 PM)

36.89

+0.99 (+2.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)01-28 2026-01-28
Inst Owners32.91%
Inst Owner Change1.21%
Ins Owners35.95%
Ins Owner Change0%
Market Cap121.00M
Revenue(TTM)66.59M
Net Income(TTM)8.98M
Analysts82.86
Price Target57.12 (54.84%)
Short Float %9.84%
Short Ratio3.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.07%
Min EPS beat(2)-24.91%
Max EPS beat(2)71.05%
EPS beat(4)3
Avg EPS beat(4)64.27%
Min EPS beat(4)-24.91%
Max EPS beat(4)153.55%
EPS beat(8)4
Avg EPS beat(8)3.28%
EPS beat(12)6
Avg EPS beat(12)4.51%
EPS beat(16)7
Avg EPS beat(16)5.14%
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)-3.54%
Revenue beat(4)2
Avg Revenue beat(4)8.06%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)20.66%
Revenue beat(8)6
Avg Revenue beat(8)11.15%
Revenue beat(12)9
Avg Revenue beat(12)10.3%
Revenue beat(16)12
Avg Revenue beat(16)11.18%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.56
Fwd PE 15.2
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 3.3
P/tB 3.31
EV/EBITDA 10
EPS(TTM)3.19
EY8.65%
EPS(NY)2.43
Fwd EY6.58%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS20.3
BVpS11.17
TBVpS11.16
PEG (NY)N/A
PEG (5Y)1.06
Graham Number28.31
Profitability
Industry RankSector Rank
ROA 14.68%
ROE 24.52%
ROCE 22.95%
ROIC 17.81%
ROICexc 21.05%
ROICexgc 21.06%
OM 16.05%
PM (TTM) 13.49%
GM 29.3%
FCFM N/A
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA 0.78
Cap/Depr 100.57%
Cap/Sales 1.87%
Interest Coverage 13.06
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.23
Quick Ratio 1.71
Altman-Z 6
F-Score6
WACC8.32%
ROIC/WACC2.14
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.68%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.04%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-155.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-127.02%
OCF growth 3YN/A
OCF growth 5YN/A

PRO-DEX INC / PDEX FAQ

Can you provide the ChartMill fundamental rating for PRO-DEX INC?

ChartMill assigns a fundamental rating of 5 / 10 to PDEX.


Can you provide the valuation status for PRO-DEX INC?

ChartMill assigns a valuation rating of 5 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.


Can you provide the profitability details for PRO-DEX INC?

PRO-DEX INC (PDEX) has a profitability rating of 7 / 10.


Can you provide the expected EPS growth for PDEX stock?

The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.